IHC Marker - Kappa Light Chain Test
About IHC Marker - Kappa Light Chain Test
| Field | Value |
|---|---|
| Also Known As | Kappa Light Chain Immunostain Test, IHC Kappa Test, Immunohistochemistry Kappa Light Chain Test, Kappa Immunoperoxidase Stain Test |
| Sample Type | FFPE Tissue Block (formalin-fixed paraffin-embedded tissue) |
| Fasting Required | No |
| Report Time | 7 days |
| Recommended For | Adults of any gender with suspected lymphoma, multiple myeloma, or plasma cell disorders |
| Price | Starting at ₹1,920 |
What Is an IHC Marker - Kappa Light Chain Test?
The IHC marker - kappa light chain test is a specialised tissue-based test that uses immunohistochemistry (a staining technique that uses antibodies to detect specific proteins) to identify kappa light chain proteins in a tissue sample. Doctors order this test when they suspect conditions such as lymphoma, multiple myeloma, or other plasma cell disorders. It is also known as the kappa light chain immunostain test, IHC kappa test, immunohistochemistry kappa light chain test, or kappa immunoperoxidase stain test. This test is performed on a formalin-fixed paraffin-embedded (FFPE) tissue block obtained through a biopsy.
What Does an IHC Marker - Kappa Light Chain Test Measure?
This test detects and evaluates kappa light chains in tissue. Kappa light chains are proteins that form part of the structure of antibodies. They pair with immunoglobulin heavy chains to create complete antibody molecules, which are central to the body's immune response.
The table below summarises what the test assesses:
| Parameter | What It Indicates |
|---|---|
| Kappa light chain expression | Immunoglobulin proteins produced by B cells and plasma cells; their presence and pattern is assessed in the tissue sample |
Why Is an IHC Marker - Kappa Light Chain Test Done?
This test is ordered when a doctor needs to examine tissue for signs of abnormal immune cell growth.
Common Symptoms That May Require This Test
The following symptoms may prompt a doctor to request this test:
- Persistent bone pain without an obvious cause
- Unexplained fatigue and weakness
- Signs of anaemia, such as paleness or breathlessness
- Recurrent or unusual infections
- Unexplained weight loss
- Swollen lymph nodes
- Elevated creatinine levels, suggesting possible kidney involvement
Conditions This Test Can Help Detect
This test assists in identifying several conditions affecting the immune system and blood:
- Multiple myeloma (a cancer of plasma cells in the bone marrow)
- Monoclonal gammopathy of undetermined significance (MGUS), a condition involving abnormal proteins in the blood
- Plasmacytoma (a plasma cell tumour)
- Non-Hodgkin's lymphomas and B-cell leukaemias
- Cutaneous B-cell lymphomas (lymphomas affecting the skin)
- Amyloidosis (a disorder where abnormal proteins deposit in organs)
IHC Marker - Kappa Light Chain Test for Chronic Disease Monitoring
This test is used not only for initial diagnosis but also to monitor the progress of conditions such as multiple myeloma and lymphomas. Doctors may repeat the IHC kappa test during or after treatment to assess how well the disease is responding. It helps pathologists track whether abnormal clonal cell populations are increasing, reducing, or stable over time.
How to Prepare and What to Expect
No special preparation is required for the IHC marker – kappa light chain test itself. However, there are a few things to keep in mind before your appointment.
Do You Need to Fast?
No fasting is required for this test. The sample is a tissue block obtained through a biopsy procedure, not a blood draw. Your doctor may give separate preparation instructions specific to the biopsy procedure.
Practical Tips Before Your Test
Here are some practical steps to follow before your test:
- Bring a detailed clinical history including your symptoms, previous test results, and family history, as this is required for the test.
- Inform your doctor about all medications you are currently taking, including prescription medicines, over-the-counter medicines, vitamins, and supplements.
- Let your doctor know about any ongoing treatments such as chemotherapy or radiation, as these may affect test results.
Step-by-Step Procedure
The IHC marker - kappa light chain test procedure involves both a biopsy and laboratory processing. Here is what to expect:
- A tissue sample is obtained through a biopsy (for example, a bone marrow, lymph node, or skin biopsy). This is performed separately as a clinical procedure before the IHC test.
- The collected tissue is preserved using formalin and embedded in paraffin wax to create a stable tissue block, which is then submitted to the laboratory.
- Thin slices of the tissue block are placed on glass slides in the laboratory.
- Specialised antibodies that bind specifically to kappa light chain proteins are applied to the slides. These antibodies carry a detectable marker, making the target proteins visible under a microscope.
- A pathologist examines the stained slides and assesses the pattern of kappa light chain expression.
- Results are interpreted in the context of the patient's clinical information and then compiled into a report.
Factors That Can Affect Accuracy
Several factors can influence the reliability of results:
- Poor tissue fixation or inadequate formalin exposure before processing
- Delays between tissue collection and processing
- Certain medications or ongoing treatments that alter cell populations
- Pre-existing conditions such as kidney failure, which affects how light chains are cleared from the body
- Chronic inflammation or autoimmune conditions, which may produce confounding patterns
- Technical factors such as antibody quality and antigen retrieval methods used in the laboratory
Understanding Your IHC Marker - Kappa Light Chain Test Results
Results from the IHC kappa test are interpreted by a pathologist and should always be reviewed with your treating doctor. The table below summarises what different patterns generally indicate:
| Result Pattern | General Interpretation |
|---|---|
| Mixed kappa- and lambda-positive cells (polyclonal) | Suggests a reactive, non-cancerous cell population |
| Predominantly kappa positive (kappa restriction) | Suggests a clonal (abnormal) cell population; may indicate malignancy |
| Negative | Kappa light chains not detected; may indicate non-B-cell origin |
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
Results During Special Conditions
Certain conditions can make results more difficult to interpret:
- Kidney failure can cause free light chains to accumulate in the blood and tissues, as the kidneys are responsible for clearing these proteins. This may affect how results are read.
- In cases of chronic inflammation or autoimmune disease, a reactive polyclonal pattern may be present, which requires careful differentiation from a true clonal process.
- High background staining in tissue sections can also be a technical limitation, particularly in formalin-fixed samples.
How to Maintain Healthy Levels
The following general tips may support your overall health, particularly if you have risk factors for plasma cell disorders:
- Attend regular check-ups and report any persistent symptoms such as bone pain, fatigue, or recurrent infections to your doctor promptly.
- If you have been previously diagnosed with MGUS or another precursor condition, follow your doctor's recommended monitoring schedule.
- Maintain a balanced diet and healthy lifestyle to support overall immune function, as advised by your healthcare provider.
Lupin Diagnostics IHC Marker - Kappa Light Chain Test Price
The IHC marker - kappa light chain test cost starts at ₹1,920 at Lupin Diagnostics. This test requires a visit to a hospital; home collection is not available for this test, as it requires a tissue biopsy performed by a qualified physician. The table below shows indicative prices across major cities:
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 1920 |
| CHENNAI | 1920 |
| HYDERABAD | 1920 |
| KOLKATA | 1920 |
| NAVI MUMBAI | 1920 |
| PUNE | 1920 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Follow these steps for IHC marker - kappa light chain test online booking:
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred centre location.
- Visit the centre at your scheduled time to submit the FFPE tissue block.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Frequently Asked Questions
This test helps doctors determine whether an abnormal collection of immune cells in tissue is cancerous or non-cancerous. It is commonly used to investigate conditions such as multiple myeloma, non-Hodgkin's lymphoma, and plasmacytoma. The test identifies whether cells are producing only kappa light chains, which can indicate a clonal and potentially malignant population.
The test itself is not painful. However, the tissue sample must be obtained through a biopsy, which may cause some discomfort depending on the site and method used. Your doctor will explain the biopsy procedure and what to expect.
No specific fasting or preparation is required for the test itself. You should bring a detailed clinical history and any previous biopsy reports. Your doctor may give specific preparation instructions for the biopsy procedure if it has not already been performed.
Kappa restriction means that the cells in the tissue sample are producing predominantly kappa light chains rather than a normal mixture of kappa and lambda. This suggests the cells may originate from a single clone, which can indicate a malignant condition such as multiple myeloma or B-cell lymphoma. Your doctor will interpret this finding alongside your full clinical picture.
Abnormal results should be discussed with your treating doctor, who may refer you to a haematologist or oncologist for further evaluation. Additional tests may be needed to confirm a diagnosis. An abnormal result on its own is not a diagnosis; it is one part of a broader clinical assessment.
At Lupin Diagnostics, the report is typically delivered within 7 days. You will receive your report digitally via email or WhatsApp.
IHC Marker - Kappa Light Chain Test
